Log in to save to my catalogue

Bruton’s Tyrosine Kinase Targeting in Multiple Myeloma

Bruton’s Tyrosine Kinase Targeting in Multiple Myeloma

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8198777

Bruton’s Tyrosine Kinase Targeting in Multiple Myeloma

About this item

Full title

Bruton’s Tyrosine Kinase Targeting in Multiple Myeloma

Publisher

MDPI

Journal title

International journal of molecular sciences, 2021-05, Vol.22 (11), p.5707

Language

English

Formats

Publication information

Publisher

MDPI

Subjects

Subjects and topics

More information

Scope and Contents

Contents

Multiple myeloma (MM), a clonal plasma cell disorder, disrupts the bones’ hematopoiesis and microenvironment homeostasis and ability to mediate an immune response against malignant clones. Despite prominent survival improvement with newer treatment modalities since the 2000s, MM is still considered a non-curable disease. Patients experience disease...

Alternative Titles

Full title

Bruton’s Tyrosine Kinase Targeting in Multiple Myeloma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8198777

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8198777

Other Identifiers

ISSN

1422-0067

E-ISSN

1422-0067

DOI

10.3390/ijms22115707

How to access this item